Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Isunakinra by Buzzard Pharmaceuticals for Pancreatic Cancer: Likelihood of Approval
Isunakinra is under clinical development by Buzzard Pharmaceuticals and currently in Phase II for Pancreatic Cancer. According to GlobalData, Phase...
Isunakinra by Buzzard Pharmaceuticals for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Isunakinra is under clinical development by Buzzard Pharmaceuticals and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma). According to...
Isunakinra by Buzzard Pharmaceuticals for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
Isunakinra is under clinical development by Buzzard Pharmaceuticals and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to...
Isunakinra by Buzzard Pharmaceuticals for Solid Tumor: Likelihood of Approval
Isunakinra is under clinical development by Buzzard Pharmaceuticals and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
Isunakinra by Buzzard Pharmaceuticals for Colorectal Cancer: Likelihood of Approval
Isunakinra is under clinical development by Buzzard Pharmaceuticals and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase...
Isunakinra by Buzzard Pharmaceuticals for Prostate Cancer: Likelihood of Approval
Isunakinra is under clinical development by Buzzard Pharmaceuticals and currently in Phase II for Prostate Cancer. According to GlobalData, Phase...
Isunakinra by Buzzard Pharmaceuticals for Anal Cancer: Likelihood of Approval
Isunakinra is under clinical development by Buzzard Pharmaceuticals and currently in Phase II for Anal Cancer. According to GlobalData, Phase...